Skip to main content

About Us

Developing the next generation of targeted cancer therapies

Delivering superior precision medicines via the integration of advanced technologies and scientific excellence

Our world-class team is comprised of experts in cancer biology, medicinal chemistry, next-generation chemical proteomics, computational chemistry and molecular biophysics, machine learning, and drug development.

Our fully integrated discovery platform is built upon the most advanced technologies available for drug discovery, small molecule design, and target identification that we believe will enable us to rapidly create highly selective small molecule compounds against an unprecedented spectrum of targets.

Our Approach

Our Vision

Transform the lives of cancer patients by pioneering the new era of

Precision Oncology 2.0™

Recognition

Leadership Team

Academic Founders

Board of Directors

Scientific Advisors